Role of chemokine receptor 2 in rheumatoid arthritis: A research update

被引:8
|
作者
Chen, Weile [1 ]
Zhu, Xiangling [1 ]
Xu, Zhen [1 ]
Jiang, Haifeng [1 ]
Wu, Xuming [1 ]
Hong, Wenming [2 ]
Wang, Xinming [2 ]
Tu, Jiajie [1 ,3 ]
Wei, Wei [1 ,3 ]
机构
[1] Anhui Med Univ, Inst Clin Pharmacol, Anhui Collaborat Innovat Ctr Antiinflammatory & Im, Key Lab Antiinflammatory & Immune Med,Minist Educ, Hefei, Peoples R China
[2] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China
[3] 81 Meishan Rd, Hefei, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
CCR2; CCL2; Rheumatoid arthritis; Rheumatoid arthritis -related cells; Therapeutic target; FIBROBLAST-LIKE SYNOVIOCYTES; COLLAGEN-INDUCED ARTHRITIS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PRO-INFLAMMATORY CYTOKINES; ADJUVANT-INDUCED ARTHRITIS; OXIDATIVE STRESS; DISEASE-ACTIVITY; CCR2; EXPRESSION; CELLS;
D O I
10.1016/j.intimp.2023.109755
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Rheumatoid arthritis (RA) is a multisystemic and inflammatory autoimmune disease characterized by joint destruction. The C-C motif chemokine receptor 2 (CCR2) is mainly expressed in monocytes and T cells, initiating their migration to sites of inflammation, ultimately leading to cartilage damage and bone destruction. CCR2 has long been considered a prospective target for treating autoimmune diseases. However, clinical studies on in-hibitors or neutralizing antibodies against CCR2 in RA have exhibited limited efficacy. Recent evidence indicates that CCR2 may play different roles in RA. Hence, a comprehensive understanding regarding the role of CCR2 may facilitate the development of targeted drugs and provide novel insights for improving CCL2-mediated inflam-matory diseases. This review summarizes the biological characteristics of CCR2, the related signaling pathways, and recent developments in CCR2-targeting therapeutics.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Chemokines and chemokine receptors as promising targets in rheumatoid arthritis
    Murayama, Masanori A.
    Shimizu, Jun
    Miyabe, Chie
    Yudo, Kazuo
    Miyabe, Yoshishige
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [2] Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
    Fukuda, Shin
    Kohsaka, Hitoshi
    Takayasu, Aiko
    Yokoyama, Waka
    Miyabe, Chie
    Miyabe, Yoshishige
    Harigai, Masayoshi
    Miyasaka, Nobuyuki
    Nanki, Toshihiro
    BMC MUSCULOSKELETAL DISORDERS, 2014, 15
  • [3] Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis
    Elemam, Noha Mousaad
    Hannawi, Suad
    Maghazachi, Azzam A.
    IMMUNOTARGETS AND THERAPY, 2020, 9 : 43 - 56
  • [4] Treg Cells in Rheumatoid Arthritis: An Update
    Cooles, Faye A. H.
    Isaacs, John D.
    Anderson, Amy E.
    CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (09)
  • [5] CC Chemokine Receptor Small Molecule Antagonists in the Treatment of Rheumatoid Arthritis and Other Diseases: A Current View
    Liu, Jinqi
    Merritt, J. Robert
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (13) : 1250 - 1267
  • [6] Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis
    Marotte, Hubert
    Ruth, Jeffrey H.
    Campbell, Phillip L.
    Koch, Alisa E.
    Ahmed, Salahuddin
    RHEUMATOLOGY, 2010, 49 (03) : 467 - 479
  • [7] Update on the role of extracellular vesicles in rheumatoid arthritis
    Miao, Hai-Bing
    Wang, Fang
    Lin, Shu
    Chen, Zhen
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2022, 24
  • [8] MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in Rheumatoid Arthritis
    Elmesmari, Aziza
    Fraser, Alasdair R.
    Wood, Claire
    Gilchrist, Derek
    Vaughan, Diane
    Stewart, Lynn
    McSharry, Charles
    McInnes, Iain B.
    Kurowska-Stolarska, Mariola
    RHEUMATOLOGY, 2016, 55 (11) : 2056 - 2065
  • [9] Immunomodulatory role of T helper cells in rheumatoid arthritis A COMPREHENSIVE RESEARCH REVIEW
    Luo, P.
    Wang, P.
    Xu, J.
    Hou, W.
    Xu, P.
    Xu, K.
    Liu, L.
    BONE & JOINT RESEARCH, 2022, 11 (07): : 426 - 438
  • [10] Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases
    Szekanecz, Z.
    Koch, A. E.
    Tak, P. P.
    NETHERLANDS JOURNAL OF MEDICINE, 2011, 69 (09) : 356 - 366